Roche Sues Mylan Over Generic Xeloda ANDA
Hoffmann-La Roche Inc. has sued generic-drug manufacturer Mylan Pharmaceuticals Inc. for allegedly infringing a patent for the oral chemotherapy drug Xeloda after learning of Mylan's intent to make and sell a...To view the full article, register now.
Already a subscriber? Click here to view full article